Packaged foods: strict salt targets could prevent 40K cardiovascular events
31 October, 2024Around 40,000 cardiovascular events could be prevented by making Australian packaged food manufacturers follow stringent targets for sodium levels.
Spider venom heart drug to enter human trials
08 October, 2024A project to develop a drug to treat heart attack and protect donor hearts is set to move to human clinical trials, following a $17.8 million funding boost.
Tool to predict risk of sudden cardiac arrest
27 September, 2024A new gene mutation-specific test will help predict the severity of heart arrhythmia that could cause sudden cardiac arrest.
Cost of hospital readmissions 'disproportionally high': study
18 September, 2024UQ researchers analysed data from more than 165,000 hospitalisations for heart failure in all public and most private hospitals in Australia from 2013 to 2017.
Australian-designed model for heart attack, stroke prevention
09 August, 2024Researchers have designed a novel health economic model to inform different health interventions and treatment plans for people at risk of heart attack and stroke.
Progress on new hypertension and lipid guidelines
02 August, 2024Around 4.5 million Australian adults have high blood pressure and 8.5 million have abnormal blood lipid levels. Each is a major risk factor for cardiovascular disease and stroke.
Prediction model for cardiac arrest treatment
30 July, 2024When treating cardiac arrests, rapid action can improve the chance of survival.
Roadmap to improve blood pressure control rates
15 July, 2024The National Hypertension Taskforce has published a roadmap to improve Australia's blood pressure control rates from the current 32% to 70% by 2030.
High-intensity interval training boosts brain function for years
10 July, 2024Aging is one of the biggest risks for dementia, a condition that affects almost half a million Australians.
Combining diabetes drugs offers heart, kidney benefits: study
09 July, 2024SGLT2is, also called gliflozins, are a class of drug that lower blood glucose by increasing its excretion in the urine, while GLP-1RAs, such as Ozempic, work by enhancing insulin release and sensitivity.
Social factors that may reduce CVD risk: men vs women
06 June, 2024Monash University-led research has identified differences in social factors that may reduce cardiovascular disease (CVD) risk for men and women.
Heart failure device could prevent hospitalisation
14 May, 2024The device may be able to detect signs of fluid overload and could be used to monitor patients with heart failure.
SJG Bendigo Hospital expands cardiac care service
13 May, 2024The service has six cardiologists rostered onsite to provide diagnosis and treatment as part of the service.
Australian regions with high cardiac arrest rates and low CPR: study
26 April, 2024Australia has about 26,000 out-of-hospital cardiac arrests annually, with only 12% of patients treated by ambulance surviving to hospital discharge and/or 30 days.
Non-invasive tests may miss heart failure in AF patients: study
03 April, 2024Existing non-invasive screening tools may miss heart failure amongst patients with atrial fibrillation (AF) and should be used with caution, suggests latest research from the University of Adelaide (UA).
